These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35745448)

  • 21. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability.
    Thadkala K; Nanam PK; Rambabu B; Sailu C; Aukunuru J
    Int J Pharm Investig; 2014 Jul; 4(3):131-7. PubMed ID: 25126526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisolvent precipitation for the preparation of high polymeric procyanidin nanoparticles under ultrasonication and evaluation of their antioxidant activity in vitro.
    Liu Z; Yang L
    Ultrason Sonochem; 2018 May; 43():208-218. PubMed ID: 29555277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
    Zu Y; Wu W; Zhao X; Li Y; Zhong C; Zhang Y
    Int J Pharm; 2014 Dec; 477(1-2):148-58. PubMed ID: 25455767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Huang Y; Zu Y; Zhao X; Wu M; Feng Z; Deng Y; Zu C; Wang L
    Int J Pharm; 2016 Sep; 511(2):921-30. PubMed ID: 27515291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
    Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
    Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
    Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
    Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of process parameters for preparation of polystyrene PM2.5 particles by supercritical antisolvent method using BBD-RSM.
    Zhang Z; Li Q; Guo B; Zhang S; Zhang S; Hu D
    Sci Rep; 2020 Jul; 10(1):11187. PubMed ID: 32636462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-solvent precipitation for the preparation of nobiletin nano-particles under ultrasonication-cis/reverse homogenization.
    Zhang X; Guo T; Liu X; Kuang W; Zhong Y; Zhang M; Huang Y; Liu Z
    Ultrason Sonochem; 2023 Jun; 96():106433. PubMed ID: 37163955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability.
    Qiu L; Zhao X; Zu Y; Zhang Y; Liu Y; Wu W; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):610-621. PubMed ID: 30831030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of ultrafine fenofibrate powder by solidification process from emulsion.
    Huang QP; Wang JX; Zhang ZB; Shen ZG; Chen JF; Yun J
    Int J Pharm; 2009 Feb; 368(1-2):160-4. PubMed ID: 19010406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
    Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissolution enhancement of gliclazide using ultrasound waves and stabilizers in liquid anti-solvent precipitation.
    Al-Nimry SS; Qandil AM; Salem MS
    Pharmazie; 2014 Dec; 69(12):874-80. PubMed ID: 25951659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of particle design on micromeritic property of dental ulcer powder].
    Zhang DK; Qin CF; Han L; Lin JZ; Wang NM; Guo ZP; Yang M
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):334-40. PubMed ID: 23668004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation, characterization and dissolution characteristics of dragon's blood extract nanosuspensions].
    Wang LF; Chen XN; Li J; Tu PF; Wang JL
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2236-2243. PubMed ID: 31359648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension.
    Kakran M; Sahoo NG; Li L; Judeh Z; Wang Y; Chong K; Loh L
    Int J Pharm; 2010 Jan; 383(1-2):285-92. PubMed ID: 19781606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
    Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.